Rethinking Keratoplasty for Patients with Acanthamoeba Keratitis: Early “Low Load Keratoplasty” in Contrast to Late Optical and Therapeutic Keratoplasty
Microorganisms · 30.08.2024 · 12 (9) · 1801
DOI: 10.3390/microorganisms12091801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 30.08.2024. Verfasst von Yaser Abu Dail und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Saarland University Medical Center, Kirrberger Straße, Building 22, 66421 Homburg/Saar, Germany. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Early therapeutic penetrating keratoplasty (TKP) for Acanthamoeba keratitis (AK) is thought to have a worse visual prognosis than the delayed optical penetrating keratoplasty (OKP) after successful conservative treatment of AK. This has led to a tendency to prolong conservative therapy and delay penetrating keratoplasty in patients with AK. This retrospective series presents the results of patients with AK that underwent early penetrating keratoplasty after reducing the corneal amoeba load through intensive conservative therapy, so-called “low load keratoplasty” (LLKP). Patients and methods: The medical records of our department were screened for patients with AK, confirmed by histological examination and/or PCR and/or in vivo confocal microscopy, which underwent ab LLKP and had a follow-up time of at least one year between 2009 and 2023. Demographic data, best corrected visual acuity (BCVA) and intraocular pressure at first and last visit, secondary glaucoma (SG), and recurrence and graft survival rates were assessed.
Results
28 eyes of 28 patients were included. The average time from initiation of therapy to penetrating keratoplasty (PKP) was 68 ± 113 days. The mean follow-up time after LLKP was 53 ± 42 months. BCVA (logMAR) improved from 1.9 ± 1 pre-operatively to 0.5 ± 0.6 at last visit (p < 0.001). A total of 14% of patients were under medical therapy for SG at the last visit, and two of them underwent glaucoma surgery. The recurrence rate was 4%. The Kaplan–Meier graft survival rate of the first graft at four years was 70%. The second graft survival rate at four years was 87.5%.
Conclusion
LLKP appears to achieve a good visual prognosis with an earlier visual and psychological habilitation, as well as low recurrence and SG rates. These results should encourage us to reconsider the optimal timing of PKP in therapy-resistant AK.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Saarland University Medical Center, Kirrberger Straße, Building 22, 66421 Homburg/Saar, Germany.
- Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, 66421 Homburg/Saar, Germany.
ORCID-Profile: Yaser Abu Dail, Elias Flockerzi, Cristian Munteanu, Berthold Seitz
Zitieren
APA
Abu Dail, Y., Flockerzi, E., Munteanu, C., Szentmáry, N., Seitz, B., & Daas, L. (2024). Rethinking Keratoplasty for Patients with Acanthamoeba Keratitis: Early “Low Load Keratoplasty” in Contrast to Late Optical and Therapeutic Keratoplasty. Microorganisms, 12(9), 1801. https://doi.org/10.3390/microorganisms12091801
Vancouver
Abu Dail Y, Flockerzi E, Munteanu C, Szentmáry N, Seitz B, Daas L. Rethinking Keratoplasty for Patients with Acanthamoeba Keratitis: Early “Low Load Keratoplasty” in Contrast to Late Optical and Therapeutic Keratoplasty. Microorganisms. 2024;12(9):1801. doi:10.3390/microorganisms12091801
BibTeX
@article{AbuDail2024,
author = {Abu Dail, Yaser and Flockerzi, Elias and Munteanu, Cristian and Szentmáry, Nóra and Seitz, Berthold and Daas, Loay},
title = {Rethinking Keratoplasty for Patients with Acanthamoeba Keratitis: Early “Low Load Keratoplasty” in Contrast to Late Optical and Therapeutic Keratoplasty},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {9},
pages = {1801},
doi = {10.3390/microorganisms12091801}
}
EUVIMED